Chiyachantana Mr.Chiraphol Chiyachantana Ms.Kusuma Palaprom Two of these four directors jointly sign and seal of the Company. Mr.Chirasak Chiyachantana Mrs.Sangsri Chiyachantana Ms. Jatechanya Boonchaleo Two of

notice of offer to purchase from SPI, the Company put up a “For Sale” sign in an effort to attract other possible interested investors in order to compare the offer price from third parties. However, from

% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share

seminar co-hosted by PAPC, SEC, Faculty of Law, CU, FPTI and ACIOA shows the vigorous sign that all sectors place importance to and recognize benefits of personal data protection. In addition, the first

- net of income tax, as an amount of ฿ 20.47 million, causing the company to have total comprehensive loss for the total period of ฿ 28.06 million. Nonetheless the company keeps continuing to adjust

. All of these activities have strategically succeeded. Nonetheless the company will continue to adjust itself toward fully digital format, for its further growth and sustainability. In the first quarter

have strategically succeeded. Nonetheless the company will continue to adjust itself toward fully digital format, for its further growth and sustainability. In the first quarter of the fiscal year 2019

considering the capacity, readiness, and size of businesses. It also discussed the potential use of a phased approach to adjust the scope of regulations according to the specific context of in each country

comments on the proposed amendments to the regulations regarding  advertising by digital asset business operators. The key points are as follows:          (1) Adjust the font size of the warning notices in

(1) adjust the accounting of the change in the shareholding proportion in KAL as the acquisition of an asset or a group of assets according to the relevant financial reporting standards, and (2